Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Effects of obesity in breast cancer patients

Dr Clifford Hudis – Memorial Sloan Kettering Cancer Center, New York, USA

Effects of obesity in breast cancer patients ( Dr Clifford Hudis – Memorial Sloan Kettering Cancer Center, New York, USA )

The AZURE translational study

Prof Robert Coleman - Weston Park Hospital, University of Sheffield, UK

The AZURE translational study ( Prof Robert Coleman - Weston Park Hospital, University of Sheffield, UK )

Exercise benefit to lifespan may be due to stem cell increase

Dr Mariusz Ratajczak - James Graham Brown Cancer Center, University of...

Exercise benefit to lifespan may be due to stem cell increase ( Dr Mariusz Ratajczak - James Graham Brown Cancer Center, University of Louisville, Kentucky, USA )

Diagnosis of blood cancer after a breast cancer diagnosis

Prof Antonio Wolff - The Johns Hopkins Hospital, Baltimore, USA

Diagnosis of blood cancer after a breast cancer diagnosis ( Prof Antonio Wolff - The Johns Hopkins Hospital, Baltimore, USA )

Histone deacetylases targeted as new strategy against graft versus host disease

Prof Sung Choi - University of Michigan, Ann Arbor, USA

Histone deacetylases targeted as new strategy against graft versus host disease ( Prof Sung Choi - University of Michigan, Ann Arbor, USA )

Ponatinib for CML and Philadelphia chromosome-positive acute lymphoblastic...

Dr Jorge Cortes - MD Anderson Cancer Center, Houston, TX, USA

Ponatinib for CML and Philadelphia chromosome-positive acute lymphoblastic leukaemia ( Dr Jorge Cortes - MD Anderson Cancer Center, Houston, TX, USA )

HDAC inhibition sensitises triple-negative breast cancer cells to PARP...

Dr Kapil Bhalla - University of Kansas Cancer Center, Kansas City, USA

HDAC inhibition sensitises triple-negative breast cancer cells to PARP inhibition ( Dr Kapil Bhalla - University of Kansas Cancer Center, Kansas City, USA )

Quizartinib for FLT3-ITD positive AML after second-line chemo or stem cell...

Dr Mark Levis - Johns Hopkins Medicine, Baltimore, USA

Quizartinib for FLT3-ITD positive AML after second-line chemo or stem cell transplant ( Dr Mark Levis - Johns Hopkins Medicine, Baltimore, USA )

A need for clarity in clinical trial end points

Dr Clifford Hudis – Memorial Sloan Kettering Cancer Center, New York, USA

A need for clarity in clinical trial end points ( Dr Clifford Hudis – Memorial Sloan Kettering Cancer Center, New York, USA )

The BTK inhibitor ibrutinib (PCI-32765) in combination with rituximab

Prof Jan Burger - The University of Texas MD Anderson Cancer Center, Houston...

The BTK inhibitor ibrutinib (PCI-32765) in combination with rituximab ( Prof Jan Burger - The University of Texas MD Anderson Cancer Center, Houston, USA )

Uncovering new targets for treatment of chronic lymphocytic leukaemia

Dr John Byrd - The Ohio State University Comprehensive Cancer Center, Columbus...

Uncovering new targets for treatment of chronic lymphocytic leukaemia ( Dr John Byrd - The Ohio State University Comprehensive Cancer Center, Columbus, USA )

Neratinib shows beneficial effects in the treatment of HER2 mutated breast...

Prof Ron Bose – Washington University School of Medicine, St. Louis, USA

Neratinib shows beneficial effects in the treatment of HER2 mutated breast cancer ( Prof Ron Bose – Washington University School of Medicine, St. Louis, USA )

More from ecancer